接种北京生物新冠疫苗（国药疫苗）后出现上肢深静脉血栓形成：一例病例报告。
Upper extremity deep vein thrombosis following BBIBP-CorV COVID-19 vaccine (Sinopharm vaccine): A case report.
作者信息
Riazi Ali, Faghih Dinevari Masood, Abbasian Samaneh, Jabbaripour Sarmadian Amirreza
机构信息
Liver and Gastrointestinal Diseases Research Center Tabriz University of Medical Sciences Tabriz Iran.
出版信息
Clin Case Rep. 2023 Jun 13;11(6):e7535. doi: 10.1002/ccr3.7535. eCollection 2023 Jun.
KEY CLINICAL MESSAGE
In patients with acute symptoms such as pain, swelling, and erythema of the upper extremities shortly after receiving COVID-19 vaccines, even inactivated virus vaccines, these symptoms may indicate thrombosis, which may be due to the vaccination.
ABSTRACT
BBIBP-CorV COVID-19 vaccine (Sinopharm vaccine) is an inactivated whole virus vaccine to control the COVID-19 pandemic. Studies concluded that inactivated COVID-19 vaccines do not increase the risk of thrombosis. This report presents a 23-year-old man with the chief complaint of severe pain, swelling, and erythema of the right upper extremity following his second dose of the Sinopharm vaccine. Duplex ultrasound of the right upper extremity revealed upper extremity deep vein thrombosis, and treatment started with oral anticoagulation. It is probably the first upper extremity deep vein thrombosis case following inactivated COVID-19 vaccines.
关键临床信息
在接种新冠疫苗后不久出现上肢疼痛、肿胀和红斑等急性症状的患者中，即使是灭活病毒疫苗，这些症状也可能提示血栓形成，这可能与接种疫苗有关。
摘要
BBIBP-CorV新冠疫苗（国药疫苗）是一种用于控制新冠疫情的灭活全病毒疫苗。研究得出结论，新冠灭活疫苗不会增加血栓形成风险。本报告介绍了一名23岁男性，在接种第二剂国药疫苗后，主要表现为右上肢严重疼痛、肿胀和红斑。右上肢的双功超声显示上肢深静脉血栓形成，治疗从口服抗凝开始。这可能是首例接种新冠灭活疫苗后出现的上肢深静脉血栓形成病例。
Zotero 插件